Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0114-0006 in Active Rheumatoid Arthritis
NCT01647451Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2012
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of NNC0114-0000-0005 in rheumatoid arthritis (RA), sponsored by Novo Nordisk. Started Sep 2012; status: completed.
02
Drugs
NNC0114-0000-0005
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01647451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01647451.